Pharmaceutical Stocks To Follow Today – April 26th

Eli Lilly and Company, Merck & Co., Inc., AbbVie, Gilead Sciences, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded up $25.21 during midday trading on Friday, hitting $884.94. 3,395,903 shares of the company traded hands, compared to its average volume of 3,439,006. Eli Lilly and Company has a 52 week low of $677.09 and a 52 week high of $972.53. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The firm has a 50 day moving average of $827.69 and a 200-day moving average of $818.61. The stock has a market cap of $839.07 billion, a price-to-earnings ratio of 75.57, a PEG ratio of 1.40 and a beta of 0.51.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Merck & Co., Inc. stock traded up $2.99 during midday trading on Friday, reaching $82.83. 28,374,477 shares of the stock traded hands, compared to its average volume of 11,891,688. The stock has a market cap of $208.88 billion, a P/E ratio of 12.31, a PEG ratio of 0.77 and a beta of 0.40. The stock’s fifty day moving average is $87.05 and its 200-day moving average is $95.23. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. Merck & Co., Inc. has a 12 month low of $75.93 and a 12 month high of $134.63.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of ABBV traded up $5.59 during mid-day trading on Friday, hitting $185.96. 10,480,961 shares of the stock were exchanged, compared to its average volume of 6,064,215. The firm has a 50-day moving average of $196.85 and a two-hundred day moving average of $187.23. AbbVie has a 52-week low of $153.58 and a 52-week high of $218.66. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66. The company has a market cap of $328.96 billion, a PE ratio of 77.48, a price-to-earnings-growth ratio of 1.62 and a beta of 0.55.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

GILD traded down $2.98 during trading hours on Friday, hitting $103.17. The company’s stock had a trading volume of 14,207,970 shares, compared to its average volume of 7,526,289. Gilead Sciences has a 12 month low of $62.07 and a 12 month high of $119.96. The company has a current ratio of 1.50, a quick ratio of 1.20 and a debt-to-equity ratio of 1.24. The business’s 50-day moving average price is $109.21 and its 200-day moving average price is $98.15. The stock has a market cap of $128.46 billion, a price-to-earnings ratio of 278.84, a P/E/G ratio of 0.71 and a beta of 0.32.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of Johnson & Johnson stock traded down $0.39 during trading hours on Friday, reaching $154.54. The company’s stock had a trading volume of 8,642,889 shares, compared to its average volume of 7,921,502. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.11 and a quick ratio of 0.86. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.99. The firm has a 50 day moving average price of $159.48 and a 200-day moving average price of $154.88. The stock has a market cap of $372.42 billion, a P/E ratio of 23.24, a P/E/G ratio of 2.56 and a beta of 0.49.